top of page
New York Office
Index IQ.png

Who We Are


IndexIQ, a New York Life Investments Company, is a trusted global provider of innovative financial solutions. Our origins date back to 2006 when we began to develop proprietary, systematic approaches to capturing the core benefits of traditional hedge funds. Since then, IndexIQ has emerged as leading provider of Liquid Alt ETFs.
As a natural complement to our Liquid Alt ETFs, and through our relationships with New York Life Investments’ boutique firms we have expanded our ETF offerings to include additional ESG, Muni, High Yield, 50% Currency Hedged International, and Core-focused solutions that leverage the domain expertise of these asset managers in a cost-effective, liquid, and transparent ETF format.

​

Liquid Alt ETFs

​

Our flagship Liquid Alt ETFs – IQ Hedge Multi-Strategy Tracker ETF (QAI) and IQ Merger Arbitrage ETF (MNA) – are among the two largest Liquid Alt ETFs on the market. . Now, more than a decade after launching QAI and MNA, IndexIQ remains a pioneer within the Liquid Alt ETF space.

​

To further our commitment to providing clients with actionable insights on Liquid Alt ETFs, we recently sponsored a project with Greenwich Associates to conduct interviews with 107 institutional investors (consultants, corporates, public funds, family offices, foundations and endowments, etc.) to determine how they perceive Liquid Alt ETFs and how they are being used in institutional portfolio allocations.


Among the key observations derived from this endeavor include:

​

  • The primary benefits of Liquid Alt ETFs: attractive fees, enhanced liquidity, improved portfolio diversification, heightened transparency

  • The top portfolio applications of Liquid Alt ETFs: transition management, replacement for higher cost fund-of-funds allocations, alpha / beta separation, core replacement

  • The projected growth projection of Liquid Alt ETFs: institutional use of Liquid Alt ETFs is predicted to more than double in the near future

​

​

 

Contact:
Chris Hempstead
Director: Institutional Business Development
P:212-576-4422
M: 914-306-1610
Email: chempstead@indexiq.com
Website: nylifeinvestments.com

​

​

​

​

bottom of page